GH Research (GHRS) Current Leases (2023 - 2025)

GH Research (GHRS) recorded quarterly Current Leases of $365000.0 in Q4 2025, up 43.14% quarter-over-quarter from $255000.0 in Q4 2024, and up 43.14% on a YoY basis from $255000.0 in Q4 2024.

GH Research (GHRS) Current Leases (2023 - 2025) Analysis & Trends

GH Research's Current Leases history runs 3 years deep, the most recent figure standing at $365000.0 for Q4 2025.

  • In Q4 2025, Current Leases rose 43.14% year-over-year to $365000.0; the TTM figure through Dec 2025 stood at $365000.0 (up 43.14% YoY), while the FY2025 annual figure was $365000.0, up 43.14% from the prior year.
  • Current Leases was $365000.0 for Q4 2025 at GH Research, up from $255000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $365000.0 in Q4 2025 to a low of $255000.0 in Q4 2024.
  • Historically, Current Leases has averaged $321000.0 across 3 years, with a median of $343000.0 in 2023.
  • The sharpest annual moves came in 2024 and 2025: Current Leases decreased 25.66% in 2024, then jumped 43.14% in 2025.
  • A 3-year view of Current Leases shows it stood at $343000.0 in 2023, then fell by 25.66% to $255000.0 in 2024, then surged by 43.14% to $365000.0 in 2025.
  • The last three Current Leases figures came in at $365000.0 (Q4 2025), $255000.0 (Q4 2024), and $343000.0 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 42,980.09
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 83,991.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 7.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 GH Research 10.10 Bn 10.00 Bn - 365,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 365,000.00
Dec 31, 2024 255,000.00
Dec 31, 2023 343,000.00